Don t Fall For This Xarelto Lawsuit Scam

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to accomplish so might be grounds for compensation. Our lawyers are operating hard to get those hurt by the drug the compensation they are entitled to. Even though bleeding is a common complication associated with anticoagulants, it has been alleged that Xarelto is much more harmful than standard blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the occasion of an emergency, individuals may be at danger for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging. In the event you or possibly a loved 1 suffered a severe bleeding occasion after taking Xarelto, you might have legal recourse. For far more data, speak to us nowadays to have your case reviewed, free of charge of charge. Compensation Possibilities xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in situations of death, funeral costs. Moreover, they're searching for punitive damages, which are typically awarded to punish the defendant and deter other businesses from acting similarly. Why Are Lawsuits Being Filed? Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several xarelto customer service lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege serious and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug. In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging: The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors. The makers of the drug continue to market Xarelto as a safe anticoagulant option. Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication. Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event. Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting. Visit this page for a lot more data on the alleged health risks of Xarelto. Multidistrict Litigation Trial Dates Set The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.